Published in Retina

What Ophthalmology Residents Should Know About Phacovitrectomy

This is editorially independent content
7 min read

Discover surgical pearls for performing phacovitrectomy to streamline care by simultaneously treating cataracts and retinal pathology.

What Ophthalmology Residents Should Know About Phacovitrectomy
It is estimated that up to 52% of patients will require cataract surgery within 1 year of undergoing vitrectomy, and approximately 80% will develop a visually significant cataract within 2 years.1
Balancing and timing cataract and retina surgeries can be a logistical challenge, with patients and surgeons alike facing the task of coordinating timing and managing delays between procedures. Phacovitrectomy offers a potential solution.

Phacovitrectomy: An overview

Phacovitrectomy refers to performing cataract surgery (phacoemulsification) at the time of pars plana vitrectomy (PPV) for retinal pathology. The main advantage of this technique is that it is a single surgical event, reducing patient exposure to anesthesia and associated costs. It features a single recovery period compared to a staged procedure.2-5
Phacovitrectomy is also advantageous to the retina surgeon as it allows for an improved view of the retina during PPV.4 Phacovitrectomy is more commonly performed in Europe than in the US,6 despite similar visual and refractive outcomes compared to vitrectomy followed by cataract surgery.3-5,7,8

Significant studies on phacovitrectomy

A prospective comparative study between 60 eyes that underwent phacovitrectomy and 60 eyes that underwent phacoemulsification alone found no differences in myopic shift or intraocular lens (IOL) displacement.3 Additionally, one extensive retrospective review of 648 eyes undergoing phacovitrectomy found that best-corrected visual acuity (BCVA) improved from 20/192 to 20/46 at 12-month follow-up, with few complications and no cases of endophthalmitis.4
Many other studies have demonstrated the safety and efficacy of phacovitrectomy. Some retinal surgeons will additionally perform a posterior capsulotomy during phacovitrectomy to obviate the potential need for a YAG capsulotomy at a later date.9
Since virtually all patients who undergo a vitrectomy develop cataract progression within 2 years,10 addressing both pathologies in a single surgical encounter is often practical.

Patient selection for phacovitrectomy

Careful pre-operative evaluation is essential; important considerations and documentation of comorbidities that may affect surgical outcomes include:
  • General ocular comorbidities: Corneal disease (e.g., Fuchs’ dystrophy) can impact outcomes, as decompensation during longer surgical procedures can obscure the view to the fundus and cause scleral thinning, zonular instability, or advanced cataract
  • Posterior segment pathology: Macular disease (e.g., epiretinal membrane, macular hole), possibly contraindicating the use of premium IOLs
  • Anatomic variables possibly compromising IOL power accuracy:
  • Patient factors: Counsel patients about the increased procedural time and complexity associated with a single event versus spreading out the time and complexity over multiple surgeries spanning multiple months

Advantages of combined surgery

Phacovitrectomy offers advantages both to the patient and the retina specialist. The primary advantage is the ability to combine cataract extraction and vitrectomy into a single, streamlined surgical procedure. This reduces the patient’s number of trips to the operating room, post-operative visits, and anesthesia exposure, while facilitating a faster visual recovery.
The approach is particularly beneficial for patients with multiple systemic comorbidities or intellectual disability, for whom repeated anesthesia exposures may increase the risk of anesthesia-related morbidity. It also reduces the total surgical cost and provides environmental benefits by decreasing the number of surgical events, associated material costs, and waste.
From the surgeon’s standpoint, performing cataract extraction before PPV improves visualization of the posterior segment, especially in the presence of significant lens opacity. It facilitates a more complete shave of the vitreous base without concern for lens touch.
Additionally, if complications such as posterior capsular rupture or lens drop occur, the retina surgeon is already present and equipped to address them immediately. Lastly, cataract surgery is technically easier when performed before vitrectomy, as the vitreous provides posterior support to the lens.
Phacovitrectomy pearls

Disadvantages of phacovitrectomy

There are potential downsides to phacovitrectomy. The combined procedure is inherently more complex than either procedure alone. Combined surgery increases operative time, which may lead to corneal decompensation, especially in patients with underlying corneal pathology (e.g., Fuchs’ dystrophy).
Moreover, some insurance providers offer reduced reimbursement for the second procedure when both are performed during a single surgical event. As previously mentioned, given the multiple wounds in the eye from the cataract surgery and the vitrectomy ports, there is a higher risk of hypotony and IOL decentration or prolapse, so care must be taken to avoid these complications. Iridocapsular adhesion is more common in phacovitrectomy.
Additionally, IOL optic prolapse anteriorly from a gas bubble is more prevalent in phacovitrectomy. IOL power calculations may also be less accurate in patients with retinal pathology (e.g., macular edema, retinal detachment). Silicone IOLs should not be used if silicone oil tamponade is planned. It is possible to have prolonged post-operative inflammation in long, complicated cases.
For retina surgeons who may not feel comfortable performing cataract surgery, it is recommended to either be experienced with phacoemulsification or work simultaneously with an anterior segment surgeon.

To learn more about IOL power calculations, check out How to Calculate IOL Power: A Guide for Ophthalmology Residents!

In conclusion

Phacovitrectomy is a valuable technique in modern vitreoretinal surgery that enables the treatment of cataracts and retinal pathology simultaneously.
It offers significant advantages for both the patient and surgeon by reducing surgical burden, anesthesia exposure, and clinic visits, while providing better visualization for the retina surgeon without sacrificing visual outcomes.
Newer machines, such as the Alcon Unity, Bausch + Lomb Stellaris Elite, and DORC EVA Nexus, provide an even easier way to facilitate phacovitrectomy in a setting that doesn’t require two machines.
  1. Markatia Z, Hudson J, Leung EH, et al. The Post Vitrectomy Cataract. Int Ophthalmol Clin. 2022 Jul 1;62(3):79-91. doi: 10.1097/IIO.0000000000000440
  2. Tranos PG, Allan B, Balidis M, et al. Comparison of postoperative refractive outcome in eyes undergoing combined phacovitrectomy vs cataract surgery following vitrectomy. Graefe’s Arch Clin Exp Ophthalmol. 2020;258(5):987-993. doi:10.1007/s00417-019-04583-w
  3. Sato T, Korehisa H, Shibata S, Hayashi K. Prospective Comparison of Intraocular Lens Dynamics and Refractive Error between Phacovitrectomy and Phacoemulsification Alone. Ophthalmol Retin. 2020;4(7):700-707. doi:10.1016/j.oret.2020.01.022
  4. Muns SM, Villegas VM, Murray TG, et al. Clinical Outcomes of Combined Phacoemulsification With Intraocular Lens Placement and Microincision Vitrectomy in Adult Vitreoretinal Disease. J Vitreoretin Dis. 2022;7(1):27-32. doi:10.1177/24741264221118185
  5. Sisk RA, Murray TG. Combined phacoemulsification and sutureless 23-gauge pars plana vitrectomy for complex vitreoretinal diseases. Br J Ophthalmol. 2010;94(8):1028-1032. doi:10.1136/bjo.2009.175984
  6. Loukovaara S, Haukka J. Repair of primary RRD – comparing pars plana vitrectomy procedure with combined phacovitrectomy with standard foldable intraocular lens implantation. Clin Ophthalmol. 2018;12:1449-1457. doi:10.2147/OPTH.S171451
  7. Tan A, Bertrand-Boiché M, Angioi-Duprez K, et al. OUTCOMES OF COMBINED PHACOEMULSIFICATION AND PARS PLANA VITRECTOMY FOR RHEGMATOGENOUS RETINAL DETACHMENT: A Comparative Study. Retina. 2021;41(1):68-74. doi:10.1097/IAE.0000000000002803
  8. Benson MD, Sia D, Seamone ME, et al. PHACOVITRECTOMY FOR PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT REPAIR: A Retrospective Review. Retina. 2021;41(4):753-760. doi:10.1097/IAE.0000000000002945
  9. Hertzberg SNW, Veiby NCBB, Bragadottir R, et al. Cost-effectiveness of the triple procedure – phacovitrectomy with posterior capsulotomy compared to phacovitrectomy and sequential procedures. Acta Ophthalmol. 2020;98(6):592-602. doi:10.1111/aos.14367
  10. Do DV, Gichuhi S, Vedula SS, Hawkins BS. Surgery for postvitrectomy cataract. Cochrane Database Syst Rev. 2018;1(1):CD006366. doi:10.1002/14651858.CD006366.pub4
  11. Apple DJ, Federman JL, Krolicki TJ, et al. Irreversible silicone oil adhesion to silicone intraocular lenses: A clinicopathologic analysis. Ophthalmology. 1996;103(10):1555-1561. doi:10.1016/S0161-6420(96)30463-6
Tobin Thuma, DO
About Tobin Thuma, DO

Tobin Thuma grew up in St. Helena, California. He graduated from UC Berkeley with a bachelor's degree in biochemistry and a minor in Spanish. After finishing college, Tobin taught English in Mallorca, Spain before deciding to pursue medicine. Earlier this year he graduated from Touro College of Osteopathic Medicine in New York City. Tobin is now completing the Bradway Research Scholar fellowship in pediatric ophthalmology at Wills Eye Hospital in Philadelphia. He is applying to ophthalmology residency programs this year.

Tobin Thuma, DO
Richard Polo, MD
About Richard Polo, MD

Richard Polo, MD, was born and raised in Los Angeles and studied chemical and biological engineering with a minor in engineering biology at Princeton University. Following his undergraduate studies, he spent 2 years conducting clinical research at an ophthalmology practice, focusing on clinical trials in vitreoretinal surgery.

Dr. Polo then attended Rutgers Robert Wood Johnson Medical School, where he served as president of the Biomedical Entrepreneurship Network, fostering meaningful connections between medical innovation and patient care. He is currently a third-year ophthalmology resident at the Weill Cornell Graduate School of Medical Sciences in New York.

Outside of medicine, Richard enjoys testing the limits of all-you-can-eat Korean BBQ and sushi spots, petting every dog he meets, and soaking up as much sunshine as possible.

Richard Polo, MD
Harris Ahmed DO, MPH
About Harris Ahmed DO, MPH

Harris Ahmed DO, MPH is a vitreoretinal surgery fellow physician at Weill Cornell. He is a leader in health policy, serving in national leadership positions in multiple organizations including the AMA, AOCOOHNS, and AOA. He has authored many publications and given lectures on public health advocacy and health policy, specializing in topics such as scope of practice, physician distribution, and medical education. He is currently serving on the board of Trustees for the California Academy of Eye Physicians and Surgeons.

Harris Ahmed DO, MPH
Omar Shakir, MD, MBA
About Omar Shakir, MD, MBA

Dr. Omar Shakir, MD, MBA, is a board-certified ophthalmologist with extensive experience in eye care and a visionary pioneer in office-based retina surgery. As the CEO and founder of Coastal Eye, he specializes in cataract and vitreoretinal surgery, utilizing the latest technologies and most advanced techniques to ensure top-quality care for his patients. Dr. Shakir is also a Clinical Instructor at Yale University, where he shares his expertise with the next generation of eye care professionals. Under his leadership, Coastal Eye participates in clinical trials, positioning the practice at the forefront of ophthalmic innovation and advancements.

Omar Shakir, MD, MBA
How would you rate the quality of this content?
Eyes On Eyecare Site Sponsors
Astellas Logo